Evaluating the Effects of Intermittent Oro-esophageal in Tracheotomy Patients With Neurogenic Dysphagia
Launched by CAPITAL MEDICAL UNIVERSITY · Jan 19, 2025
Trial Information
Current as of September 08, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a new way to provide nutrition to patients who have trouble swallowing due to nerve damage, a condition known as neurogenic dysphagia. This often affects people with neurological diseases like stroke or Parkinson's. Some patients may need a tracheotomy, which is a procedure that helps them breathe. The trial aims to compare two feeding methods to see which one better helps these patients improve their swallowing ability while still meeting their nutritional needs.
To participate in this trial, individuals must have been diagnosed with neurogenic dysphagia and should be in a stable health condition after their acute phase. They need to have had their tracheotomy for at least a week and be able to tolerate a certain amount of feeding through a pump. Participants will be asked to sign a consent form, and they should not have any serious swallowing problems caused by physical blockages or severe cognitive issues that would prevent them from cooperating. This study hopes to improve the quality of life for patients by finding effective ways to support their nutrition and swallowing.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Diagnosis of neurogenic dysphagia;
- • Acute phase has passed, weaning time \> 48 hours, tracheotomy time \>1 week; in accordance with the decannulation process of tracheotomy patients formulated by our center in 2018;
- • steady vital signs, without severe cognitive impairment or sensory aphasia, able to cooperate with the assessment;
- • Gastrointestinal motility is good, can tolerate more than 150ml/h feeding pump speed;
- • Willing to sign an informed consent form.
- Exclusion Criteria:
- • Structural swallowing disorders, such as oral, pharyngeal, larynx, esophagus and other anatomical abnormalities caused by swallowing disorders;
- • The clinical condition was unstable, accompanied by heart, lung, brain and other important organ dysfunction;
- • Severe cognitive dysfunction, confusion, unable to cooperate.
About Capital Medical University
Capital Medical University is a leading institution in medical education and research, dedicated to advancing healthcare through innovative clinical trials. With a strong emphasis on scientific rigor and ethical standards, the university collaborates with a network of healthcare professionals and researchers to drive breakthroughs in medical science. Capital Medical University aims to enhance patient care and improve health outcomes by fostering a multidisciplinary approach to clinical research, ensuring that its trials are designed to address critical health challenges and contribute valuable insights to the medical community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported